Showing 11-20 of 2293 results for "".
MS Masters Toolbox: Cramps, Spasms, and Spasticity
https://practicalneurology.com/programs/practical-neurology/cramps-spasms-and-spasticity/31200/In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 4 provides too- Navigating the Maze of MS Managementhttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pn0207-ms-mngmnt-pdf/31217/Advancements in Multiple Sclerosis Management: A Comprehensive OverviewMultiple sclerosis (MS) remains a complex neurological disorder, presenting significant challenges for both patients and neurologists. Despite the availability of several effective immunomodulatory therapies, managing MS often in
The MS Treatment Landscape: MSAA's 2014 MS Research Update Provides Vital Information to Medical Professionals, Members of the MS Community
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-ms-treatment-landscape-msaas-2014-emms-research-updateem-provides-vital-information-to-medical-professionals-members-of-the-ms-community/30677/New publication compiles the latest developments in MS research.New Guidelines for MS Treatment
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/new-guidelines-for-ms-treatment/30239/Will new guidelines address variability in the care of patients with MS?Advancements in MS Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/advancements-in-ms-therapy/30862/New oral agents—approved and in the pipeline—may instigate an evolution in the treatment of MS.- Defining the Spectrum of MS Treatment Goalshttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0106mstreatmentgoals-pdf/31355/Evolving Outcome Measures and Therapeutic Developments in Multiple SclerosisNathan Hall’s article in the January 2006 issue of *Practical Neurology* provides a comprehensive overview of the evolving landscape of outcome measures and treatment strategies in multiple sclerosis (MS). As MS research adv
- MS Diagnosis: Sizing Up the Suspectshttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pn0205pg52-56-pdf/31493/Diagnosing multiple sclerosis (MS) remains one of the most challenging tasks in neurology due to its diverse clinical presentations and numerous mimicking conditions. In Jeffrey I. Greenstein’s February 2005 article in *Practical Neurology*, the complexities of differentiating MS from other neurolog
- What to Expect When the MS Patient is Expectinghttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0708MSPregFea-pdf/31007/Multiple sclerosis (MS) typically manifests in individuals during their late 20s, with an average onset age of 28 for women and early 30s for men. Relapsing-remitting MS is the most prevalent form, predominantly affecting females, while primary progressive MS shows equal incidence across genders. Re
Overactive Bladder in MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/overactive-bladder-in-ms/30190/Functional imaging studies suggest neurogenic overactive bladder in people with MS may differ from idiopathic overactive bladder.- Bad Reception: When MS Patients Are on a Different Wavelengthhttps://practicalneurology.com/columns/practice-management/bad-reception-when-ms-patients-are-on-a-different-wavelength/31064/Enhancing Physician-Patient Relationships to Improve MS Patient RetentionMaintaining strong physician-patient alliances is crucial in managing Multiple Sclerosis (MS), a chronic and unpredictable neurological disorder. According to a January 2008 article in Practical Neurology, MS patients frequentl